文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

视网膜下液外引流术辅助治疗伴重度渗出性视网膜脱离的Coats病5年疗效分析

[Analysis of 5-year efficacy of adjuvant external drainage of subretinal fluid therapy in Coats disease with severe exudative retinal detachment].
PubMed 文献 · Zhonghua Yan Ke Za Zhi · 2025-01-01

回顾性病例系列研究纳入23例(23只眼)伴重度渗出性视网膜脱离的3B期青少年型Coats病患者,行视网膜下液外引流术联合抗VEGF药物、视网膜光凝和(或)冷凝术。末次随访时所有患眼视网膜异常血管完全或部分闭锁、视网膜下液完全吸收或明显减少;但玻璃体纤维化、视网膜下纤维化、牵拉性视网膜脱离和并发性白内障等并发症发生率较高,视力治疗前后差异无统计学意义。

要点

  • 23只眼末次随访时视网膜异常血管均完全或部分闭锁,视网膜下液完全吸收或明显减少,无因疾病进展行眼球摘除者。
  • 发生玻璃体纤维化17只眼(73.9%)、视网膜下纤维化21只眼(91.3%)、牵拉性视网膜脱离12只眼(52.2%)、视网膜囊肿5只眼(21.7%)、并发性白内障15只眼(65.2%)。
  • 牵拉性视网膜脱离的发生与视网膜异常血管区钟点数较多(OR=2.04,95%CI:1.14~3.64,P=0.016)及并发性白内障(OR=73.18,95%CI:4.58~1 168.40,P=0.002)存在关联。

核心结论

  • 视网膜下液外引流术用于辅助治疗伴有重度渗出性视网膜脱离的3B期青少年型Coats病远期疗效较好,但术后可能引起牵拉性视网膜脱离和并发性白内障等并发症。

研究设计与样本

  • 回顾性病例系列研究,纳入2014年1月至2018年12月在首都医科大学附属北京同仁医院就诊的伴有重度渗出性视网膜脱离的3B期青少年型Coats病患者23例(23只眼)。

主要发现

  • 末次随访时23只眼视网膜异常血管均完全或部分闭锁,视网膜下液完全吸收或明显减少;治愈8只眼(34.8%),改善15只眼(65.2%)。
  • 治愈者玻璃体纤维化、牵拉性视网膜脱离和并发性白内障的发生率均低于改善者(均P<0.005)。
  • 15只眼行最佳矫正视力检查,治疗后提高3只眼、稳定10只眼、下降2只眼;治疗前后最佳矫正视力差异无统计学意义(P>0.05)。
  • 发生玻璃体纤维化17只眼(73.9%)、视网膜下纤维化21只眼(91.3%)、牵拉性视网膜脱离12只眼(52.2%)、视网膜囊肿5只眼(21.7%)、并发性白内障15只眼(65.2%)。
  • 并发性白内障患者牵拉性视网膜脱离发生率高于无并发性白内障者(11/15 vs. 1/8;χ2=10.96,P=0.001)。

关键数值与推荐

  • 牵拉性视网膜脱离的发生与视网膜异常血管区钟点数较多相关(OR=2.04,95%CI:1.14~3.64,P=0.016)。
  • 牵拉性视网膜脱离的发生与并发性白内障相关(OR=73.18,95%CI:4.58~1 168.40,P=0.002)。

临床怎么用

  • 原文结论认为视网膜下液外引流术是伴重度渗出性视网膜脱离的3B期青少年型Coats病的远期有效辅助治疗,但术后可能发生牵拉性视网膜脱离和并发性白内障等并发症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To study the 5-year long-term efficacy and complications of adjuvant external drainage of subretinal fluid therapy in patients with severe exudative retinal detachment (ERD) secondary to stage 3B juvenile Coats disease. Methods: This was a retrospective case series study. From January 2014 to December 2018, twenty-three eyes of 23 patients with severe ERD secondary to stage 3B juvenile Coats disease diagnosed at Beijing Tongren Hospital, Capital Medical University were included in this study. All patients underwent wide-field retinal imaging, fluorescein fundus angiography (FFA) and ocular color Doppler imaging. All cases received external drainage of subretinal fluid therapy combined with treatments including intravitreal injection of anti-vescular edothelial growth factor (VEGF) agents, retinal photocoagulation and/or cryotherapy. Clock-hour extent and occlusion of retinal vascular telangiectasia, changes of subretinal fluid, best corrected visual acuity (BCVA, logMAR) and incidences of complications including vitreous fibrosis, subretinal fibrosis, tractional retinal detachment (TRD), retinal cyst and complicated cataract were observed. Statistical analyses were performed using Fisher's exact test, corrected chi-square test and chi-square test, Mann-Whitney U test, paired-sample Wilcoxon signed-rank test and Logistic regression analysis. Results: Among 23 eyes of 23 patients, 22 patients (95.7%) were male and 1 patient (4.3%) was female. All patients had unilateral Coats disease. The median age of initial visit was 43.0 (38.0, 47.0) months (range, 26 to 129 months). The median clock-hour extent of retinal vascular telangiectasia was 9.0 (7.0, 10.0) (range, 5 to 12). The median time of external drainage of subretinal fluid therapy was 1.0 (1.0, 2.0). The median time of retinal photocoagulation was 2.0 (2.0, 3.0). The median time of intravitreal injection of anti-VEGF agents was 4.0 (3.0, 6.0). Retinal cryotherapy was performed in 14 eyes (60.9%). The median follow-up after initial treatment was 66.5 (64.0, 70.0) months (range, 60 to 89 months). At last follow-up, retinal vascular telangiectasia of all patients were completely or partially occluded, and subretinal fluid was completely absorbed or obviously reduced; of which 8 eyes (34.8%) were completely occluded, and 15 eyes (65.2%) were partially occluded. The incidences of vitreous fibrosis, TRD and complicated cataract in the completely occluded eyes were lower than those in the partially occluded eyes (all P<0.005). No global enucleation was performed in any patient because of disease progression. Among 15 eyes of 15 patients underwent BCVA examination, 3 eyes had an improved vision, 10 eyes had a stable vision and 2 eyes had a decreased vision. The difference between median BCVA after treatment and that before treatment was not statistically significant [2.6 (2.6, 2.9) vs. 2.9 (2.6, 3.2), Z=-0.14, P=0.891]. Seventeen eyes (73.9%) developed vitreous fibrosis; 21 eyes (91.3%) developed subretinal fibrosis; 12 eyes (52.2%) developed TRD, 5 eyes (21.7%) developed retinal cyst and 15 eyes (65.2%) developed complicated cataract. Patients with complicated cataract had a higher incidence of TRD than that in patients without complicated cataract (11/15 vs. 1/8; χ2=10.96, P=0.001). The occurrence of TRD was associated with the greater clock-hour extent of retinal vascular telangiectasia and the presence of complicated cataract (OR=2.04, 95%CI: 1.14-3.64, P=0.016; OR=73.18, 95%CI: 4.58-1 168.40, P=0.002). Conclusions: External drainage of subretinal fluid is a long-term effective adjuvant therapy in stage 3B juvenile Coats disease with severe ERD. However, there are possible complications such as TRD and complicated cataract after surgeries. 目的: 观察视网膜下液外引流术辅助治疗伴有重度渗出性视网膜脱离(ERD)的3B期青少年型Coats病患者的5年远期疗效和并发症。 方法: 回顾性病例系列研究。纳入2014年1月至2018年12月在首都医科大学附属北京同仁医院就诊的伴有重度ERD的3B期青少年型Coats病患者23例(23只眼)的临床资料。患者均行广角视网膜成像、荧光素眼底血管造影术和眼彩色多普勒超声检查。患眼均行视网膜下液外引流术联合玻璃体注射抗血管内皮生长因子药物以及视网膜光凝和(或)冷凝术。观察患眼视网膜异常血管区位置和范围、血管闭锁情况、视网膜下液变化、最佳矫正视力[BCVA,以最小分辨角的对数(logMAR)表示]以及玻璃体纤维化、视网膜下纤维化、牵拉性视网膜脱离(TRD)、视网膜囊肿和并发性白内障等并发症的发生情况。采用Fisher确切概率法、校正χ2检验和χ2检验、Mann-Whitney U检验、配对样本Wilcoxon符号秩检验以及Logistic回归分析进行统计学分析。 结果: 23例患者,男性22例(95.7%),女性1例(4.3%),均为单眼发病。首次就诊年龄为43.0(38.0,47.0)个月(范围:26~129个月)。视网膜异常血管区范围为9.0(7.0,10.0)个钟点数(范围:5~12个钟点数)。患者行视网膜下液外引流术1.0(1.0,2.0)次、视网膜光凝术2.0(2.0,3.0)次、抗血管内皮生长因子药物治疗4.0(3.0,6.0)次。14只眼(60.9%)行视网膜冷凝术。随访时间66.5(64.0,70.0)个月(范围:60~89个月)。末次随访时,23例患者视网膜异常血管均完全或大部分闭锁,视网膜下液完全吸收或明显减少;其中,疗效为治愈、改善者分别为8例(34.8%)、15例(65.2%)。治愈者玻璃体纤维化、TRD和并发性白内障的发生率均低于改善者(均P<0.005)。患者中无疾病进展而行眼球摘除者。15例(15只眼)患者行BCVA检查。末次治疗后BCVA提高、稳定、下降分别为3、10、2只眼,治疗前后BCVA差异无统计学意义(P>0.05)。发生玻璃体纤维化17只眼(73.9%),视网膜下纤维化21只眼(91.3%),TRD 12只眼(52.2%),视网膜囊肿5只眼(21.7%),并发性白内障15只眼(65.2%)。并发性白内障患者的TRD发生率高于未发生并发性白内障的患者(分别为11/15和1/8;χ2=10.96,P=0.001)。TRD的发生与视网膜异常血管区钟点数较多(OR=2.04,95%CI:1.14~3.64,P=0.016)以及发生并发性白内障(OR=73.18,95%CI:4.58~1 168.40,P=0.002)存在关联。 结论: 视网膜下液外引流术用于辅助治疗伴有重度ERD的3B期青少年型Coats病的远期疗效较好,但可能引起TRD和并发性白内障等术后并发症。.

来源:Zhonghua Yan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Li L, Li SF, Liu JH, et al. [Analysis of 5-year efficacy of adjuvant external drainage of subretinal fluid therapy in Coats disease with severe exudative retinal detachment]. Zhonghua Yan Ke Za Zhi. 2025. PMID: 40050102. doi:10.3760/cma.j.cn112142-20241130-00547

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。